Polystyrène sulfonate de sodium Substipharm
Polystyrène sulfonate de sodium Substipharm is a medicine authorised by Swissmedic under authorisation number 69396. The authorisation holder is Leman SKL SA. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 19 September 2024 and the authorisation is limited until 18 September 2029. ATC code V03AE01 places the medicine in the group All other therapeutic products.
| Authorisation number | 69396 |
|---|---|
| Name | Polystyrène sulfonate de sodium Substipharm |
| Full name | Polystyrène sulfonate de sodium Substipharm, poudre pour suspension orale et rectale |
| Authorisation holder | Leman SKL SA |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | V03AE01 |
| First authorisation | 19 September 2024 |
| Authorisation validity | 18 September 2029 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Polystyrène sulfonate de sodium Substipharm, poudre pour suspension orale et rectale | B | 19 September 2024 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 2 | 454 | g | V03AE01 | 16.00.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Polystyrène sulfonate de sodium Substipharm authorised in Switzerland?
Yes. Polystyrène sulfonate de sodium Substipharm is authorised by Swissmedic under authorisation number 69396, data as of 01 September 2026. The authorisation is limited until 18 September 2029.
Which dispensing category does Polystyrène sulfonate de sodium Substipharm have?
Polystyrène sulfonate de sodium Substipharm is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Polystyrène sulfonate de sodium Substipharm?
The authorisation holder is Leman SKL SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.